IPO
-
-
-
-
-
-
-
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
-
-
-
-
-
-
-
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
-
-
-
-
-
-
-
C4 Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
-
-
-
-
-
-
-
C4 Therapeutics Inc. (CCCC) Prices 9.6M Share Upsized IPO at $19/Sh
-
-
99,571 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All